海正药业 (600267)
Zhejiang Hisun Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameZhejiang Hisun Pharmaceutical Co., Ltd.
Listing Date2000-07-25
Issue Price11.83RMB
Registered Capital119884.819610k RMB
Legal RepresentativeXiao Weihong
Registered AddressNo. 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessThe company is primarily engaged in the research and development, production, and sales of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. Its specific businesses include: chemical API business, domestic finished dosage form business, biologics business, and pharmaceutical distribution business.
Company ProfileZhejiang Hisun Pharmaceutical Co., Ltd. (hereinafter referred to as "Hisun Pharma") was founded in 1956 and listed on the A-share market in 2000. In 2012, it established a joint venture with Pfizer in the branded generic drug sector, named Hisun Pfizer Pharmaceuticals Co., Ltd. The company has been selected as one of the first batch of "Innovative Enterprises" and "National Intellectual Property Demonstration Enterprises" by the state, and recognized as a "National Industrial Brand Cultivation Demonstration Enterprise". It is also listed among the "Top 100 Pharmaceutical Industrial Enterprises in China", "Top 100 Comprehensive Strength Industrial Enterprises in China's Chemical Pharmaceutical Industry", and "Top 100 Internationalized Pharmaceutical Enterprises in 2017".
Stock Details
1. Key Indicators
- Total Shares(W): 119884.82
- Circulating A-Shares(W): 119818.89
- Earnings Per Share(RMB): 0.4000
- Net Assets Per Share(RMB): 7.0989
- Operating Revenue(W RMB): 792279.42
- Total Profit(W RMB): 61973.51
- **Net Profit Attributable to Parent(W RMB) **: 46092.92
- Net Profit Growth Rate(%): -10.55
- Weighted Return on Equity(%): 5.4700
- Operating Cash Flow Per Share(RMB): 1.3720
- Undistributed Profit Per Share(RMB): 2.2969
- Capital Reserve Per Share(RMB): 3.5842
2. Main Business
The main business covers:
- Production of pharmaceuticals
- Production and sales of veterinary drugs
3. Company Basic Information
- Company Name: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Listing Date: 2000-07-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
- Website: https://www.hisunpharm.com/
- Company Profile: The company was established on February 11, 1998, as a joint stock company initiated by Zhejiang Hisun Group Co., Ltd. as the main sponsor, together with seven other units including SDIC Xingye Co., Ltd. (now renamed SDIC Pharmaceutical Investment Co., Ltd.), Sanlong Investment (China) Co., Ltd., Sichuan Institute of Antibiotics Industry under the State Pharmaceutical Administration, Shanghai Pharmaceutical Industry Research Institute under the State Pharmaceutical Administration, China Pharmaceutical University, Zhejiang Pharmaceutical Industry Company (now reorganized as Zhejiang Inte Pharmaceutical Co., Ltd.), and the Second Military Medical University Zhaohui Pharmaceutical Factory (now restructured and reorganized as Shanghai Fosun Zhaohui Pharmaceutical Co., Ltd.). At the time of establishment, the company's total share capital was 116 million shares, with the main sponsor contributing net assets converted into 86.6716 million shares; the other sponsors contributed net assets or cash, totaling 29.3284 million shares. After the public issuance of 40 million RMB ordinary shares, the company's total share capital reached 156 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Hisun Group Co., Ltd. | General Legal Person | 32078.36 | 26.77 |
| 2 | Zhejiang International Trade Group Co., Ltd. | General Legal Person | 7267.39 | 6.07 |
| 3 | Taizhou Jiaojiang State-owned Capital Operation Group Co., Ltd. | General Legal Person | 5993.15 | 5.00 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2865.04 | 2.39 |
| 5 | Southern China Securities 1000 ETF | Fund | 767.54 | 0.64 |
| 6 | Guotai Haitong China Securities 1000 Index Enhanced Securities Investment Fund Class A | Fund | 137.23 | 0.11 |
| 7 | Morgan Stanley Youyue Anhe Mixed Securities Investment Fund Class A | Fund | 33.32 | 0.03 |
| 8 | Hengyue Medical Health Selection Mixed Securities Investment Fund Class A | Fund | 16.44 | 0.01 |
| 9 | Guotai Xinli One Year Holding Period Mixed Securities Investment Fund Class A | Fund | 4.81 | 0.00 |
| 10 | Guotai Tongli 9 Month Holding Period Mixed Securities Investment Fund Class A | Fund | 3.63 | 0.00 |
5. Concept Sectors
- Generic Drugs
- Innovative Drugs
- Weight Loss Drugs
- Synthetic Biology
- Pet Economy
- DeepSeek
- Margin Trading
- Share Repurchase Plan
- Free Cash Flow
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information